MedTrace Logo

How to Reduce Suicidal Thoughts and Impulsivity in Depression

NCT05894980 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-05-14

No results posted yet for this study

Summary

The study aims at investigating if tDCS applied to left DLPFC or to right OFC to treatment as usual is effective in reducing severe suicidal ideas in major depressive episode.

Conditions

Interventions

DEVICE

active tDCS stimulating left DLPFC

20 active tDCS sessions (4 sessions/day for 5 days, 30 min each, 2 mA) applied to the left DLPFC

DEVICE

active tDCS stimulating right OFC

20 active tDCS sessions (4 sessions/day for 5 days, 30 min each, 2 mA) applied to the right OFC

DEVICE

sham tDCS

20 active tDCS sessions (4 sessions/day for 5 days, 30 min each, 0 mA) applied to the left DLPFC

Sponsors & Collaborators

  • Fondation FondaMental

    collaborator OTHER

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Principal Investigators

  • Djamila BENNABI, MD PhD · CHU de Besançon

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2025-07-31
Completion
2026-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05894980 on ClinicalTrials.gov